Display options
Share it on

Skelet Muscle. 2012 Dec 03;2(1):25. doi: 10.1186/2044-5040-2-25.

Alveolar rhabdomyosarcoma - The molecular drivers of PAX3/7-FOXO1-induced tumorigenesis.

Skeletal muscle

Amy D Marshall, Gerard C Grosveld

Affiliations

  1. Department of Genetics, St Jude Children's Research Hospital, Memphis, TN, 38105, USA. [email protected].

PMID: 23206814 PMCID: PMC3564712 DOI: 10.1186/2044-5040-2-25

Abstract

Rhabdomyosarcoma is a soft tissue sarcoma arising from cells of a mesenchymal or skeletal muscle lineage. Alveolar rhabdomyosarcoma (ARMS) is more aggressive than the more common embryonal (ERMS) subtype. ARMS is more prone to metastasis and carries a poorer prognosis. In contrast to ERMS, the majority of ARMS tumors carry one of several characteristic chromosomal translocations, such as t(2;13)(q35;q14), which results in the expression of a PAX3-FOXO1 fusion transcription factor. In this review we discuss the genes that cooperate with PAX3-FOXO1, as well as the target genes of the fusion transcription factor that contribute to various aspects of ARMS tumorigenesis. The characterization of these pathways will lead to a better understanding of ARMS tumorigenesis and will allow the design of novel targeted therapies that will lead to better treatment for this aggressive pediatric tumor.

References

  1. J Clin Oncol. 2010 May 1;28(13):2126-8 - PubMed
  2. Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1589-94 - PubMed
  3. Cancer Res. 2008 Aug 15;68(16):6587-97 - PubMed
  4. J Proteome Res. 2011 Feb 4;10(2):624-36 - PubMed
  5. Genes Chromosomes Cancer. 2000 Jun;28(2):220-6 - PubMed
  6. Mol Cancer Res. 2010 Jan;8(1):1-14 - PubMed
  7. Genes Chromosomes Cancer. 2010 Mar;49(3):224-36 - PubMed
  8. EMBO J. 1996 Jul 15;15(14):3667-75 - PubMed
  9. Int J Cancer. 2004 Jul 10;110(5):687-94 - PubMed
  10. Hum Mol Genet. 1996 Jan;5(1):15-21 - PubMed
  11. Oncogene. 2013 Jan 31;32(5):651-62 - PubMed
  12. Int J Clin Exp Pathol. 2009;2(4):370-83 - PubMed
  13. Oncogene. 1997 Sep;15(11):1309-14 - PubMed
  14. J Biol Chem. 2000 Oct 6;275(40):30801-5 - PubMed
  15. Cold Spring Harb Symp Quant Biol. 2008;73:307-15 - PubMed
  16. Clin Transl Oncol. 2012 Mar;14(3):197-206 - PubMed
  17. PLoS Biol. 2007 Aug;5(8):e192 - PubMed
  18. Proc Natl Acad Sci U S A. 2006 Sep 5;103(36):13439-44 - PubMed
  19. Cancer Res. 1989 Oct 1;49(19):5407-13 - PubMed
  20. Nat Genet. 1993 Nov;5(3):230-5 - PubMed
  21. Cancer Biol Ther. 2002 Mar-Apr;1(2):97-104 - PubMed
  22. Nature. 1995 Aug 31;376(6543):768-71 - PubMed
  23. Trends Biochem Sci. 2002 Jul;27(7):352-60 - PubMed
  24. Cancer Res. 1998 Nov 15;58(22):5009-13 - PubMed
  25. Clin Cancer Res. 2008 Jul 1;14(13):4119-27 - PubMed
  26. FEBS Lett. 1992 Aug 31;309(1):25-8 - PubMed
  27. Pediatr Dev Pathol. 2009 Jul-Aug;12(4):275-83 - PubMed
  28. Biochem Biophys Res Commun. 2008 Jan 18;365(3):568-74 - PubMed
  29. Cancer Res. 2002 Aug 15;62(16):4704-10 - PubMed
  30. Clin Cancer Res. 2012 Jul 15;18(14):3780-90 - PubMed
  31. Science. 1991 Feb 15;251(4995):802-4 - PubMed
  32. Mol Cancer. 2007 Sep 25;6:60 - PubMed
  33. Genes Chromosomes Cancer. 2002 Mar;33(3):310-21 - PubMed
  34. Nat Med. 2001 Jun;7(6):673-9 - PubMed
  35. Nature. 1991 May 9;351(6322):153-5 - PubMed
  36. Blood. 2002 Oct 1;100(7):2597-606 - PubMed
  37. Cancer. 2005 Apr 1;103(7):1475-83 - PubMed
  38. Mol Carcinog. 2012 Oct;51(10):807-15 - PubMed
  39. J Cell Biochem. 2011 May;112(5):1410-7 - PubMed
  40. Biochim Biophys Acta. 2007 Oct;1770(10):1450-8 - PubMed
  41. Cell. 1992 Jun 26;69(7):1237-45 - PubMed
  42. Cell. 2000 Sep 15;102(6):777-86 - PubMed
  43. Pediatr Blood Cancer. 2011 Feb;56(2):239-49 - PubMed
  44. Am J Pathol. 2000 Feb;156(2):399-408 - PubMed
  45. Clin Cancer Res. 2011 Mar 15;17(6):1463-73 - PubMed
  46. Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18085-90 - PubMed
  47. Mol Cell Biol. 1995 Mar;15(3):1522-35 - PubMed
  48. Clin Cancer Res. 2012 Feb 1;18(3):796-807 - PubMed
  49. Hum Mol Genet. 1996 Jun;5(6):783-8 - PubMed
  50. FASEB J. 2009 Aug;23(8):2681-90 - PubMed
  51. Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13264-9 - PubMed
  52. EMBO J. 1991 May;10(5):1135-47 - PubMed
  53. Cancer Res. 1996 Jul 15;56(14):3220-4 - PubMed
  54. Cancer Genet Cytogenet. 2005 Dec;163(2):138-43 - PubMed
  55. Med Pediatr Oncol. 2000 Aug;35(2):96-103 - PubMed
  56. J Clin Oncol. 2006 Aug 20;24(24):3844-51 - PubMed
  57. Science. 1993 Mar 5;259(5100):1450-3 - PubMed
  58. Cell Growth Differ. 1993 Dec;4(12):1065-70 - PubMed
  59. Endocrinology. 1999 Apr;140(4):1957-60 - PubMed
  60. Cancer. 1994 Apr 15;73(8):2231-7 - PubMed
  61. J Clin Oncol. 2005 Feb 1;23(4):880-8 - PubMed
  62. Am J Pathol. 2009 Feb;174(2):550-64 - PubMed
  63. Biochem J. 2000 Jul 15;349(Pt 2):629-34 - PubMed
  64. Dev Biol. 1996 Oct 10;179(1):303-8 - PubMed
  65. Int J Cancer. 2006 Jun 1;118(11):2772-81 - PubMed
  66. Cancer Res. 1987 Aug 15;47(16):4501-7 - PubMed
  67. Cell. 2004 Nov 12;119(4):543-54 - PubMed
  68. Clin Exp Metastasis. 2008;25(1):1-10 - PubMed
  69. Clin Cancer Res. 2008 Jul 15;14(14):4572-83 - PubMed
  70. Cancer Res. 2004 Mar 1;64(5):1730-6 - PubMed
  71. J Biol Chem. 1995 May 19;270(20):11719-22 - PubMed
  72. Cancer Res. 2004 Aug 15;64(16):5539-45 - PubMed
  73. Mol Cell Biol. 1999 Jan;19(1):594-601 - PubMed
  74. Lab Invest. 2004 Aug;84(8):1060-70 - PubMed
  75. Oncogene. 2004 Sep 9;23(41):6864-71 - PubMed
  76. Cancer Res. 2007 Jan 1;67(1):57-65 - PubMed
  77. Transgenic Res. 2006 Oct;15(5):595-614 - PubMed
  78. J Clin Oncol. 2002 Jun 1;20(11):2672-9 - PubMed
  79. Mol Cancer Ther. 2009 Jul;8(7):1838-45 - PubMed
  80. Cytogenet Cell Genet. 1987;45(3-4):148-55 - PubMed
  81. Exp Cell Res. 2007 Jul 1;313(11):2308-17 - PubMed
  82. Cancer Res. 2003 Nov 15;63(22):7926-35 - PubMed
  83. Cancer Res. 1998 Aug 15;58(16):3542-6 - PubMed
  84. J Pathol. 2007 Jun;212(2):143-51 - PubMed
  85. Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4213-8 - PubMed
  86. Pediatr Dev Pathol. 2003 Mar-Apr;6(2):128-36 - PubMed
  87. Mol Endocrinol. 2003 Sep;17(9):1681-92 - PubMed
  88. J Clin Oncol. 2010 Oct 10;28(29):e587-8; author reply e589-90 - PubMed
  89. Nat Med. 2002 Nov;8(11):1276-80 - PubMed
  90. J Clin Oncol. 2010 May 1;28(13):2151-8 - PubMed
  91. Development. 1996 Mar;122(3):1017-27 - PubMed
  92. Cell Growth Differ. 1999 Dec;10(12):813-8 - PubMed
  93. Oncogene. 2005 Mar 10;24(11):1860-72 - PubMed
  94. Mod Pathol. 2004 Jun;17(6):660-9 - PubMed
  95. Cancer Res. 2006 May 1;66(9):4742-9 - PubMed
  96. Am J Pathol. 2009 Dec;175(6):2600-8 - PubMed
  97. Cancer Res. 2010 Aug 15;70(16):6497-508 - PubMed
  98. Cancer Res. 2011 Dec 15;71(24):7471-80 - PubMed
  99. Histol Histopathol. 2004 Apr;19(2):401-11 - PubMed
  100. Pediatr Blood Cancer. 2005 Jun 15;44(7):643-53 - PubMed
  101. Cancer Res. 1991 Oct 1;51(19):5100-6 - PubMed
  102. Carcinogenesis. 2011 Apr;32(4):452-61 - PubMed
  103. Pediatr Blood Cancer. 2007 Dec;49(7):928-40 - PubMed
  104. Mod Pathol. 1998 Dec;11(12):1222-7 - PubMed
  105. Genes Dev. 2004 Nov 1;18(21):2614-26 - PubMed
  106. EMBO J. 2004 Aug 18;23(16):3430-9 - PubMed
  107. J Clin Invest. 2009 Nov;119(11):3395-407 - PubMed
  108. Am J Surg Pathol. 2008 Oct;32(10):1513-22 - PubMed
  109. Mol Cell Biol. 2002 Oct;22(20):7204-16 - PubMed
  110. Eur J Neurosci. 1999 Dec;11(12):4213-25 - PubMed
  111. Cancer Res. 2006 Jul 15;66(14):6936-46 - PubMed
  112. Genes Chromosomes Cancer. 2008 Jun;47(6):510-20 - PubMed
  113. Biochem Biophys Res Commun. 2007 Dec 7;364(1):105-10 - PubMed
  114. Eur J Immunol. 1997 Jul;27(7):1788-93 - PubMed
  115. Cancer Res. 1994 Jun 1;54(11):2869-72 - PubMed
  116. Oncogene. 2007 Nov 8;26(51):7267-81 - PubMed
  117. Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8479-84 - PubMed
  118. Folia Histochem Cytobiol. 2009 Jan;47(3):485-9 - PubMed
  119. Cancer Res. 2005 Sep 1;65(17):7530-2 - PubMed
  120. J Pathol. 2002 Apr;196(4):450-8 - PubMed
  121. Cancer Res. 1992 Apr 15;52(8):2243-7 - PubMed
  122. Cancer Res. 2008 Dec 1;68(23):9583-8 - PubMed
  123. Neoplasia. 1999 Oct;1(4):340-8 - PubMed
  124. Oncogene. 2013 Apr 11;32(15):1876-87 - PubMed

Publication Types